{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T19:32:47Z","timestamp":1783366367556,"version":"3.54.6"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ygyno.2016.07.100","type":"journal-article","created":{"date-parts":[[2016,7,17]],"date-time":"2016-07-17T06:49:38Z","timestamp":1468738178000},"page":"128-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Diagnostic performance and establishment of reference limits of HE4 in Korean healthy women"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9527-5853","authenticated-orcid":false,"given":"Shinae","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyosoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungho","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jung","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Yeon","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2016.07.100_bb0005","first-page":"S4","article-title":"Ovarian cancer: screening, treatment, and follow-up","volume":"55","author":"National Institutes of Health Consensus Development Conference Statement","year":"1994","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0010","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1006\/gyno.1994.1340","article-title":"Management of the adnexal mass","volume":"55","author":"Curtin","year":"1994","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2016.07.100_bb0020","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/IGC.0b013e318251c97d","article-title":"Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers","volume":"22","author":"Bast","year":"2012","journal-title":"International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0025","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1200\/JCO.2014.55.1713","article-title":"Prognosis and conditional disease-free survival among patients with ovarian cancer","volume":"32","author":"Kurta","year":"2014","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0030","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ygyno.2015.06.005","article-title":"Long-term mortality among women with epithelial ovarian cancer","volume":"138","author":"Dinkelspiel","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0035","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.ygyno.2006.08.022","article-title":"Summary and discussion of session recommendations","volume":"103","author":"Fountain","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2016.07.100_bb0040","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S0020-7292(06)60033-7","article-title":"Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"International Journal of Gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics"},{"key":"10.1016\/j.ygyno.2016.07.100_bb0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ygyno.2005.06.040","article-title":"Potential markers that complement expression of CA125 in epithelial ovarian cancer","volume":"99","author":"Rosen","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1155\/2004\/241982","article-title":"Blood and urine markers for ovarian cancer: a comprehensive review","volume":"20","author":"Terry","year":"2004","journal-title":"Dis. Markers"},{"key":"10.1016\/j.ygyno.2016.07.100_bb0055","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Hellstrom","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0060","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0065","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0070","series-title":"The Recognition and Initial Management of Ovarian Cancer. National Collaborating Centre for Cancer (UK)","author":"Ovarian Cancer","year":"2011"},{"key":"10.1016\/j.ygyno.2016.07.100_bb0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s13277-011-0256-4","article-title":"Human epididymis protein 4 reference limits and natural variation in a Nordic reference population","volume":"33","author":"Bolstad","year":"2012","journal-title":"Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"10.1016\/j.ygyno.2016.07.100_bb0080","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/ijc.26129","article-title":"Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer","volume":"130","author":"Park","year":"2012","journal-title":"International Journal of Cancer Journal International Du Cancer."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0085","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.clinbiochem.2013.08.019","article-title":"The reference intervals for HE4, CA125 and ROMA in healthy female with electrochemiluminescence immunoassay","volume":"46","author":"Yang","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0090","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1373\/clinchem.2009.140855","article-title":"A recipe for proteomics diagnostic test development: the OVA1 test, from biomarker discovery to FDA clearance","volume":"56","author":"Fung","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0095","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2011.02.022","article-title":"No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting","volume":"121","author":"Jacob","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0100","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/AOG.0b013e318224fce2","article-title":"Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass","volume":"118","author":"Moore","year":"2011","journal-title":"Obstet. Gynecol."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2016.07.100_bb0105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ijgc-00009577-200602001-00005","article-title":"Risk of malignancy index for referral of ovarian cancer cases to a tertiary center: does it identify the correct cases?","volume":"16","author":"Bailey","year":"2006","journal-title":"International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0110","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijgo.2006.10.006","article-title":"The risk of malignancy index in discrimination of adnexal masses","volume":"96","author":"Ulusoy","year":"2007","journal-title":"International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0115","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1701-2163(16)34175-5","article-title":"Risk of malignancy index in the evaluation of patients with adnexal masses","volume":"31","author":"Clarke","year":"2009","journal-title":"Journal of obstetrics and gynaecology Canada: JOGC=Journal d'obstetrique et gynecologie du Canada: JOGC."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0120","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/AOG.0b013e31823584db","article-title":"Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay","volume":"118","author":"Timmerman","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0125","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/AOG.0b013e31821b5118","article-title":"Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors","volume":"117","author":"Ueland","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/ajo.12363","article-title":"HE4, CA125, the risk of malignancy algorithm and the risk of malignancy index and complex pelvic masses \u2014 a prospective comparison in the pre-operative evaluation of pelvic masses in an Australian population","volume":"55","author":"Richards","year":"2015","journal-title":"The Australian & New Zealand Journal of Obstetrics & Gynaecology."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0135","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cca.2014.09.028","article-title":"Clinical performance of two multi-marker blood tests for predicting malignancy in women with an adnexal mass","volume":"438","author":"Grenache","year":"2015","journal-title":"Clinica Chimica Acta; International Journal of Clinical Chemistry"},{"key":"10.1016\/j.ygyno.2016.07.100_bb0140","series-title":"\u201cHow to Define and Determine Reference Intervals in the Clinical Laboratory; Approved Guideline\u2014Second Edition\u201d CLSI Document C28-A2","author":"Clinical Laboratory and Standards Institute","year":"2000"},{"key":"10.1016\/j.ygyno.2016.07.100_bb0145","series-title":"Evaluation of Precision Performance of Quantitative Measurement Methods: Approved Guideline. Wayne, PA","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.ygyno.2016.07.100_bb0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0155","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajog.2011.12.028","article-title":"Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age","volume":"206","author":"Moore","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0160","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.7314\/APJCP.2012.13.12.6391","article-title":"Human epididymis protein 4 reference intervals in a multiethnic Asian women population","volume":"13","author":"Mokhtar","year":"2012","journal-title":"Asian Pacific Journal of Cancer Prevention: APJCP."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0165","author":"U.S. Food and Drug Administration, 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY"},{"key":"10.1016\/j.ygyno.2016.07.100_bb0170","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1158\/1055-9965.EPI-12-0616","article-title":"Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancer","volume":"21","author":"Urban","year":"2012","journal-title":"Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0175","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1258\/acb.2011.011258","article-title":"Elevated human epididymis protein 4 concentrations in chronic kidney disease","volume":"49","author":"Nagy","year":"2012","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0180","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1373\/clinchem.2010.157073","article-title":"Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases","volume":"57","author":"Escudero","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0185","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1097\/IGC.0000000000000532","article-title":"HE4 as an early detection biomarker of epithelial ovarian cancer: investigations in Prediagnostic specimens from the Janus Serumbank","volume":"25","author":"Gislefoss","year":"2015","journal-title":"International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0190","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajog.2011.12.029","article-title":"Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders","volume":"206","author":"Moore","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0195","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1007\/s13277-014-1945-6","article-title":"HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer","volume":"35","author":"Ortiz-Munoz","year":"2014","journal-title":"Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"10.1016\/j.ygyno.2016.07.100_bb0200","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5468\/ogs.2013.56.4.234","article-title":"Clinical efficacy of serum human epididymis protein 4 as a diagnostic biomarker of ovarian cancer: a pilot study","volume":"56","author":"Chung","year":"2013","journal-title":"Obstetrics & Gynecology Science"},{"key":"10.1016\/j.ygyno.2016.07.100_bb0205","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ygyno.2013.07.094","article-title":"Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer","volume":"131","author":"Kristjansdottir","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.07.100_bb0210","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2012.09.034","article-title":"The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass","volume":"128","author":"Chan","year":"2013","journal-title":"Gynecol. Oncol."}],"updated-by":[{"DOI":"10.1016\/j.ygyno.2016.11.030","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000}}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816309714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816309714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T07:07:36Z","timestamp":1692428856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816309714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0090825816309714"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.07.100","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ygyno.2016.11.030","asserted-by":"object"}]},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic performance and establishment of reference limits of HE4 in Korean healthy women","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.07.100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}